WHO is Accountable Act

Bill Number

S. 774

Origin Chamber

Senate

Congress

119th Congress, Session 1

Policy Area

International Affairs

Status

Introduced

Latest Action

2025-02-27: Read twice and referred to the Committee on Foreign Relations.

Last Updated

2025-05-27T14:12:52Z

AI-Generated Summary

Purpose

The "WHO is Accountable Act" (S. 774) aims to hold the World Health Organization (WHO) accountable by prohibiting U.S. federal funding for membership or contributions until the WHO implements specific reforms addressing transparency, political influence, and operational focus.

Key Provisions

• Funding Prohibition: No federal funds may be used by any U.S. department or agency to pursue U.S. membership in the WHO or to provide required (assessed) or optional (voluntary) financial contributions.
• Certification Requirement: The prohibition remains in effect until the Secretary of State certifies to Congress that the WHO satisfies all listed conditions.
• Conditions for Compliance (all must be met):
• Adopts reforms to prevent politicization of humanitarian aid, ensuring it reaches those in greatest need.
• Demonstrates independence from control or harmful influence by the Chinese Communist Party.
• Refrains from involvement in concealing the Chinese Communist Party's handling of the COVID-19 pandemic.
• Grants observer status to Taiwan (a self-governing island not recognized as a sovereign nation by most countries, including the U.S.).
• Stops diverting humanitarian or medical supplies to Iran, North Korea, or Syria.
• Implements systems to boost transparency, accountability, and prevent waste, fraud, or abuse in its activities.
• Ends funding, involvement, or promotion of non-core issues, such as:
• "Gender identity" and related "gender affirming care" (medical or social support for individuals' gender identity).
• Climate change initiatives.
• Access to abortion services.
• Agrees that U.S. membership would not make any WHO directive legally binding on U.S. citizens or individual states.

Significant Changes to Existing Law

• This bill introduces a conditional halt to U.S. engagement with the WHO, overriding prior laws that authorize U.S. membership and funding (e.g., under the International Organizations Immunities Act and annual appropriations).
• It shifts from automatic U.S. participation—where the U.S. is currently the largest donor—to a reform-based model, potentially suspending contributions that total hundreds of millions of dollars annually.

Potential Impacts

• Government Agencies: The State Department would face new certification duties, requiring detailed assessments of WHO compliance, which could strain diplomatic resources and influence foreign aid budgeting.
• Citizens: Indirect effects include reduced U.S. influence in global health responses (e.g., pandemics or disease outbreaks), potentially limiting access to international health coordination without direct legal obligations from WHO rules.
• International Relations: Could strain ties with WHO member states, particularly China (as a major influencer), and allies reliant on U.S. funding; it might encourage Taiwan's greater involvement in global forums but isolate the U.S. from collaborative health efforts.

Main Stakeholders Affected

• U.S. Government: Primarily the State Department, Congress, and health agencies like the Centers for Disease Control and Prevention (CDC), which collaborate with the WHO.
• World Health Organization: Faces pressure for internal reforms, potential loss of U.S. funding (about 15-20% of its budget), and membership challenges.
• Other Nations and Entities: China (targeted for influence and COVID-19 actions), Taiwan (gains observer potential), and countries like Iran, North Korea, and Syria (affected by supply restrictions); global health NGOs and vulnerable populations in humanitarian crises.
• U.S. Citizens and States: Impacted through non-binding WHO directives, preserving state-level autonomy on health policies.

Notable Legal, Constitutional, or Political Implications

• Legal: The bill reinforces U.S. sovereignty by explicitly stating WHO directives lack binding force domestically, aligning with treaties that require congressional ratification for enforceability.
• Constitutional: Raises questions on separation of powers, as it involves Congress directing executive foreign policy (certification by the Secretary of State), but fits within Congress's authority over appropriations.
• Political: Highlights partisan divides on international organizations, emphasizing accountability for past events like COVID-19 origins; could signal a broader U.S. shift toward conditional multilateralism, affecting alliances and global health governance without altering treaty commitments.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Blackburn, Marsha [R-TN]

Cosponsors (4)

Sen. Barrasso, John [R-WY], Sen. Scott, Rick [R-FL], Sen. Cruz, Ted [R-TX], Sen. Ernst, Joni [R-IA]

Recent Actions

• 2025-02-27: Read twice and referred to the Committee on Foreign Relations.
• 2025-02-27: Introduced in Senate

Bill Versions

• WHO is Accountable Act — issued 2025-02-27 — PDF (3 pages)